Trial NCT01281163

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02574
Secondary IDs: 2010-109 8747 CDR0000693729 NCI-2011-02574 P30CA022453 U01CA062487 U01CA062490 WSU# 2010-109

Last trial update was posted on 2015-08-27

MeSH Interventions

Lapatinib

MeSH Conditions

Breast Neoplasms

Other Conditions

Estrogen Receptor Negative Estrogen Receptor Positive HER2/Neu Positive Progesterone Receptor Negative Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IV Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID